Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$222.55
-0.9%
$238.07
$146.12
$251.71
$535.80B0.278.45 million shs3.11 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$17.80
+0.7%
$17.67
$14.02
$25.17
$34.13B0.5534.23 million shs17.11 million shs
10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.50%-1.24%-6.81%-5.55%+45.20%
Kenvue Inc. stock logo
KVUE
Kenvue
+1.64%+2.82%+2.29%-1.96%-24.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$222.55
-0.9%
$238.07
$146.12
$251.71
$535.80B0.278.45 million shs3.11 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$17.80
+0.7%
$17.67
$14.02
$25.17
$34.13B0.5534.23 million shs17.11 million shs
10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.50%-1.24%-6.81%-5.55%+45.20%
Kenvue Inc. stock logo
KVUE
Kenvue
+1.64%+2.82%+2.29%-1.96%-24.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.67
Moderate Buy$252.4813.45% Upside
Kenvue Inc. stock logo
KVUE
Kenvue
2.19
Hold$19.338.60% Upside

Current Analyst Ratings Breakdown

Latest JNJ and KVUE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+)Buy (B)
4/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$244.00 ➝ $266.00
4/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetBuy$240.00 ➝ $275.00
4/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOutperform$237.00 ➝ $246.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$283.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingOutperform$265.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetHold$220.00 ➝ $250.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetEqual Weight$234.00 ➝ $255.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetNeutral$253.00 ➝ $254.00
4/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOutperform$237.00 ➝ $258.00
4/15/2026
Kenvue Inc. stock logo
KVUE
Kenvue
Lower Price TargetNeutral$20.00 ➝ $19.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$96.36B5.56$13.94 per share15.97$33.73 per share6.60
Kenvue Inc. stock logo
KVUE
Kenvue
$15.12B2.26$1.41 per share12.59$5.62 per share3.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6525.7317.692.2121.83%32.60%13.29%7/15/2026 (Estimated)
Kenvue Inc. stock logo
KVUE
Kenvue
$1.47B$0.7723.0815.353.949.72%19.72%7.72%5/7/2026 (Confirmed)

Latest JNJ and KVUE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Kenvue Inc. stock logo
KVUE
Kenvue
$0.27$0.32+$0.05$0.25$3.84 billion$3.91 billion
4/14/2026Q1 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion
2/17/2026Q4 2025
Kenvue Inc. stock logo
KVUE
Kenvue
$0.22$0.27+$0.05$0.17$3.68 billion$3.78 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.362.41%+5.25%61.97%64 Years
Kenvue Inc. stock logo
KVUE
Kenvue
$0.834.66%N/A107.79%1 Years

Latest JNJ and KVUE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/14/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.23%5/26/20265/26/20266/9/2026
4/29/2026
Kenvue Inc. stock logo
KVUE
Kenvue
quarterly$0.20754.82%5/13/20265/13/20265/27/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Kenvue Inc. stock logo
KVUE
Kenvue
0.66
0.96
0.68

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Kenvue Inc. stock logo
KVUE
Kenvue
97.64%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Kenvue Inc. stock logo
KVUE
Kenvue
1.59%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Kenvue Inc. stock logo
KVUE
Kenvue
22,0001.92 billion1.89 billionOptionable

Recent News About These Companies

Kenvue: Q1 Earnings Snapshot
5 Things to Know Before the Stock Market Opens
Kenvue Reports First Quarter 2026 Results
Kenvue Inc. $KVUE Shares Sold by Strs Ohio

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$222.55 -2.07 (-0.92%)
As of 02:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Kenvue stock logo

Kenvue NYSE:KVUE

$17.80 +0.12 (+0.69%)
As of 02:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.